Global Long-Acting Reversible Contraception(LARC) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Long-Acting Reversible Contraception(LARC) market size was valued at US$ 1128.9 million in 2022. With growing demand in downstream market, the Long-Acting Reversible Contraception(LARC) is forecast to a readjusted size of US$ 1722.7 million by 2029 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Long-Acting Reversible Contraception(LARC) market. Long-Acting Reversible Contraception(LARC) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Long-Acting Reversible Contraception(LARC). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Long-Acting Reversible Contraception(LARC) market.
Long-acting reversible pregnancy (LARC) is a birth control method that provides long-term pregnancy prevention. LARC can provide protection for three to 10 years or more.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Long-Acting Reversible Contraception(LARC) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Long-Acting Reversible Contraception(LARC) market. It may include historical data, market segmentation by Type (e.g., Intrauterine Devices (IUCs), Subcutaneous Implant), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Long-Acting Reversible Contraception(LARC) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Long-Acting Reversible Contraception(LARC) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Long-Acting Reversible Contraception(LARC) industry. This include advancements in Long-Acting Reversible Contraception(LARC) technology, Long-Acting Reversible Contraception(LARC) new entrants, Long-Acting Reversible Contraception(LARC) new investment, and other innovations that are shaping the future of Long-Acting Reversible Contraception(LARC).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Long-Acting Reversible Contraception(LARC) market. It includes factors influencing customer ' purchasing decisions, preferences for Long-Acting Reversible Contraception(LARC) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Long-Acting Reversible Contraception(LARC) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Long-Acting Reversible Contraception(LARC) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Long-Acting Reversible Contraception(LARC) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Long-Acting Reversible Contraception(LARC) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Long-Acting Reversible Contraception(LARC) market.
Market Segmentation:
Long-Acting Reversible Contraception(LARC) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Long-Acting Reversible Contraception(LARC) market?
What factors are driving Long-Acting Reversible Contraception(LARC) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-Acting Reversible Contraception(LARC) market opportunities vary by end market size?
How does Long-Acting Reversible Contraception(LARC) break out type, application?
According to our LPI (LP Information) latest study, the global Long-Acting Reversible Contraception(LARC) market size was valued at US$ 1128.9 million in 2022. With growing demand in downstream market, the Long-Acting Reversible Contraception(LARC) is forecast to a readjusted size of US$ 1722.7 million by 2029 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Long-Acting Reversible Contraception(LARC) market. Long-Acting Reversible Contraception(LARC) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Long-Acting Reversible Contraception(LARC). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Long-Acting Reversible Contraception(LARC) market.
Long-acting reversible pregnancy (LARC) is a birth control method that provides long-term pregnancy prevention. LARC can provide protection for three to 10 years or more.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Long-Acting Reversible Contraception(LARC) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Long-Acting Reversible Contraception(LARC) market. It may include historical data, market segmentation by Type (e.g., Intrauterine Devices (IUCs), Subcutaneous Implant), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Long-Acting Reversible Contraception(LARC) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Long-Acting Reversible Contraception(LARC) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Long-Acting Reversible Contraception(LARC) industry. This include advancements in Long-Acting Reversible Contraception(LARC) technology, Long-Acting Reversible Contraception(LARC) new entrants, Long-Acting Reversible Contraception(LARC) new investment, and other innovations that are shaping the future of Long-Acting Reversible Contraception(LARC).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Long-Acting Reversible Contraception(LARC) market. It includes factors influencing customer ' purchasing decisions, preferences for Long-Acting Reversible Contraception(LARC) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Long-Acting Reversible Contraception(LARC) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Long-Acting Reversible Contraception(LARC) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Long-Acting Reversible Contraception(LARC) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Long-Acting Reversible Contraception(LARC) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Long-Acting Reversible Contraception(LARC) market.
Market Segmentation:
Long-Acting Reversible Contraception(LARC) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Intrauterine Devices (IUCs)
- Subcutaneous Implant
- Age 20~24 Years Old
- Age 25-34 Years Old
- Age 35~44 Years Old
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Merck
- Teva Pharmaceutical
- Allergan
- HRA Pharma
- Eurogine
- Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
- Wuxi Tianyi Medical Equipment Co., Ltd.
- SMB Corporation
- Shenyang Liren
- Tianjin Hejie Medical Equipment Co., Ltd.
- Cooper Companies
- AbbVie Allergan
- Organon
- Shanghai Dahua Pharmaceutical
What is the 10-year outlook for the global Long-Acting Reversible Contraception(LARC) market?
What factors are driving Long-Acting Reversible Contraception(LARC) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-Acting Reversible Contraception(LARC) market opportunities vary by end market size?
How does Long-Acting Reversible Contraception(LARC) break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Long-Acting Reversible Contraception(LARC) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Long-Acting Reversible Contraception(LARC) by Country/Region, 2018, 2022 & 2029
2.2 Long-Acting Reversible Contraception(LARC) Segment by Type
2.2.1 Intrauterine Devices (IUCs)
2.2.2 Subcutaneous Implant
2.3 Long-Acting Reversible Contraception(LARC) Sales by Type
2.3.1 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
2.3.2 Global Long-Acting Reversible Contraception(LARC) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Type (2018-2023)
2.4 Long-Acting Reversible Contraception(LARC) Segment by Application
2.4.1 Age 20~24 Years Old
2.4.2 Age 25-34 Years Old
2.4.3 Age 35~44 Years Old
2.4.4 Other
2.5 Long-Acting Reversible Contraception(LARC) Sales by Application
2.5.1 Global Long-Acting Reversible Contraception(LARC) Sale Market Share by Application (2018-2023)
2.5.2 Global Long-Acting Reversible Contraception(LARC) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Application (2018-2023)
3 GLOBAL LONG-ACTING REVERSIBLE CONTRACEPTION(LARC) BY COMPANY
3.1 Global Long-Acting Reversible Contraception(LARC) Breakdown Data by Company
3.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Company (2018-2023)
3.1.2 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company (2018-2023)
3.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Company (2018-2023)
3.2.1 Global Long-Acting Reversible Contraception(LARC) Revenue by Company (2018-2023)
3.2.2 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company (2018-2023)
3.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Company
3.4 Key Manufacturers Long-Acting Reversible Contraception(LARC) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-Acting Reversible Contraception(LARC) Product Location Distribution
3.4.2 Players Long-Acting Reversible Contraception(LARC) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTION(LARC) BY GEOGRAPHIC REGION
4.1 World Historic Long-Acting Reversible Contraception(LARC) Market Size by Geographic Region (2018-2023)
4.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Long-Acting Reversible Contraception(LARC) Market Size by Country/Region (2018-2023)
4.2.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Long-Acting Reversible Contraception(LARC) Sales Growth
4.4 APAC Long-Acting Reversible Contraception(LARC) Sales Growth
4.5 Europe Long-Acting Reversible Contraception(LARC) Sales Growth
4.6 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Growth
5 AMERICAS
5.1 Americas Long-Acting Reversible Contraception(LARC) Sales by Country
5.1.1 Americas Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023)
5.1.2 Americas Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023)
5.2 Americas Long-Acting Reversible Contraception(LARC) Sales by Type
5.3 Americas Long-Acting Reversible Contraception(LARC) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Reversible Contraception(LARC) Sales by Region
6.1.1 APAC Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2023)
6.1.2 APAC Long-Acting Reversible Contraception(LARC) Revenue by Region (2018-2023)
6.2 APAC Long-Acting Reversible Contraception(LARC) Sales by Type
6.3 APAC Long-Acting Reversible Contraception(LARC) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-Acting Reversible Contraception(LARC) by Country
7.1.1 Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023)
7.1.2 Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023)
7.2 Europe Long-Acting Reversible Contraception(LARC) Sales by Type
7.3 Europe Long-Acting Reversible Contraception(LARC) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Reversible Contraception(LARC) by Country
8.1.1 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023)
8.2 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Type
8.3 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-Acting Reversible Contraception(LARC)
10.3 Manufacturing Process Analysis of Long-Acting Reversible Contraception(LARC)
10.4 Industry Chain Structure of Long-Acting Reversible Contraception(LARC)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-Acting Reversible Contraception(LARC) Distributors
11.3 Long-Acting Reversible Contraception(LARC) Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTION(LARC) BY GEOGRAPHIC REGION
12.1 Global Long-Acting Reversible Contraception(LARC) Market Size Forecast by Region
12.1.1 Global Long-Acting Reversible Contraception(LARC) Forecast by Region (2024-2029)
12.1.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Long-Acting Reversible Contraception(LARC) Forecast by Type
12.7 Global Long-Acting Reversible Contraception(LARC) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.1.3 Bayer Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.2.3 Merck Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Teva Pharmaceutical
13.3.1 Teva Pharmaceutical Company Information
13.3.2 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceutical Main Business Overview
13.3.5 Teva Pharmaceutical Latest Developments
13.4 Allergan
13.4.1 Allergan Company Information
13.4.2 Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.4.3 Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Allergan Main Business Overview
13.4.5 Allergan Latest Developments
13.5 HRA Pharma
13.5.1 HRA Pharma Company Information
13.5.2 HRA Pharma Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.5.3 HRA Pharma Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 HRA Pharma Main Business Overview
13.5.5 HRA Pharma Latest Developments
13.6 Eurogine
13.6.1 Eurogine Company Information
13.6.2 Eurogine Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.6.3 Eurogine Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Eurogine Main Business Overview
13.6.5 Eurogine Latest Developments
13.7 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
13.7.1 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Company Information
13.7.2 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.7.3 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Main Business Overview
13.7.5 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Latest Developments
13.8 Wuxi Tianyi Medical Equipment Co., Ltd.
13.8.1 Wuxi Tianyi Medical Equipment Co., Ltd. Company Information
13.8.2 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.8.3 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Wuxi Tianyi Medical Equipment Co., Ltd. Main Business Overview
13.8.5 Wuxi Tianyi Medical Equipment Co., Ltd. Latest Developments
13.9 SMB Corporation
13.9.1 SMB Corporation Company Information
13.9.2 SMB Corporation Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.9.3 SMB Corporation Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 SMB Corporation Main Business Overview
13.9.5 SMB Corporation Latest Developments
13.10 Shenyang Liren
13.10.1 Shenyang Liren Company Information
13.10.2 Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.10.3 Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shenyang Liren Main Business Overview
13.10.5 Shenyang Liren Latest Developments
13.11 Tianjin Hejie Medical Equipment Co., Ltd.
13.11.1 Tianjin Hejie Medical Equipment Co., Ltd. Company Information
13.11.2 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.11.3 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tianjin Hejie Medical Equipment Co., Ltd. Main Business Overview
13.11.5 Tianjin Hejie Medical Equipment Co., Ltd. Latest Developments
13.12 Cooper Companies
13.12.1 Cooper Companies Company Information
13.12.2 Cooper Companies Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.12.3 Cooper Companies Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Cooper Companies Main Business Overview
13.12.5 Cooper Companies Latest Developments
13.13 AbbVie Allergan
13.13.1 AbbVie Allergan Company Information
13.13.2 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.13.3 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AbbVie Allergan Main Business Overview
13.13.5 AbbVie Allergan Latest Developments
13.14 Organon
13.14.1 Organon Company Information
13.14.2 Organon Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.14.3 Organon Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Organon Main Business Overview
13.14.5 Organon Latest Developments
13.15 Shanghai Dahua Pharmaceutical
13.15.1 Shanghai Dahua Pharmaceutical Company Information
13.15.2 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.15.3 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Shanghai Dahua Pharmaceutical Main Business Overview
13.15.5 Shanghai Dahua Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Long-Acting Reversible Contraception(LARC) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Long-Acting Reversible Contraception(LARC) by Country/Region, 2018, 2022 & 2029
2.2 Long-Acting Reversible Contraception(LARC) Segment by Type
2.2.1 Intrauterine Devices (IUCs)
2.2.2 Subcutaneous Implant
2.3 Long-Acting Reversible Contraception(LARC) Sales by Type
2.3.1 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
2.3.2 Global Long-Acting Reversible Contraception(LARC) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Type (2018-2023)
2.4 Long-Acting Reversible Contraception(LARC) Segment by Application
2.4.1 Age 20~24 Years Old
2.4.2 Age 25-34 Years Old
2.4.3 Age 35~44 Years Old
2.4.4 Other
2.5 Long-Acting Reversible Contraception(LARC) Sales by Application
2.5.1 Global Long-Acting Reversible Contraception(LARC) Sale Market Share by Application (2018-2023)
2.5.2 Global Long-Acting Reversible Contraception(LARC) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Application (2018-2023)
3 GLOBAL LONG-ACTING REVERSIBLE CONTRACEPTION(LARC) BY COMPANY
3.1 Global Long-Acting Reversible Contraception(LARC) Breakdown Data by Company
3.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Company (2018-2023)
3.1.2 Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company (2018-2023)
3.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Company (2018-2023)
3.2.1 Global Long-Acting Reversible Contraception(LARC) Revenue by Company (2018-2023)
3.2.2 Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company (2018-2023)
3.3 Global Long-Acting Reversible Contraception(LARC) Sale Price by Company
3.4 Key Manufacturers Long-Acting Reversible Contraception(LARC) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-Acting Reversible Contraception(LARC) Product Location Distribution
3.4.2 Players Long-Acting Reversible Contraception(LARC) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTION(LARC) BY GEOGRAPHIC REGION
4.1 World Historic Long-Acting Reversible Contraception(LARC) Market Size by Geographic Region (2018-2023)
4.1.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Long-Acting Reversible Contraception(LARC) Market Size by Country/Region (2018-2023)
4.2.1 Global Long-Acting Reversible Contraception(LARC) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Long-Acting Reversible Contraception(LARC) Sales Growth
4.4 APAC Long-Acting Reversible Contraception(LARC) Sales Growth
4.5 Europe Long-Acting Reversible Contraception(LARC) Sales Growth
4.6 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Growth
5 AMERICAS
5.1 Americas Long-Acting Reversible Contraception(LARC) Sales by Country
5.1.1 Americas Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023)
5.1.2 Americas Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023)
5.2 Americas Long-Acting Reversible Contraception(LARC) Sales by Type
5.3 Americas Long-Acting Reversible Contraception(LARC) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Reversible Contraception(LARC) Sales by Region
6.1.1 APAC Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2023)
6.1.2 APAC Long-Acting Reversible Contraception(LARC) Revenue by Region (2018-2023)
6.2 APAC Long-Acting Reversible Contraception(LARC) Sales by Type
6.3 APAC Long-Acting Reversible Contraception(LARC) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-Acting Reversible Contraception(LARC) by Country
7.1.1 Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023)
7.1.2 Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023)
7.2 Europe Long-Acting Reversible Contraception(LARC) Sales by Type
7.3 Europe Long-Acting Reversible Contraception(LARC) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Reversible Contraception(LARC) by Country
8.1.1 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023)
8.2 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Type
8.3 Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-Acting Reversible Contraception(LARC)
10.3 Manufacturing Process Analysis of Long-Acting Reversible Contraception(LARC)
10.4 Industry Chain Structure of Long-Acting Reversible Contraception(LARC)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-Acting Reversible Contraception(LARC) Distributors
11.3 Long-Acting Reversible Contraception(LARC) Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTION(LARC) BY GEOGRAPHIC REGION
12.1 Global Long-Acting Reversible Contraception(LARC) Market Size Forecast by Region
12.1.1 Global Long-Acting Reversible Contraception(LARC) Forecast by Region (2024-2029)
12.1.2 Global Long-Acting Reversible Contraception(LARC) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Long-Acting Reversible Contraception(LARC) Forecast by Type
12.7 Global Long-Acting Reversible Contraception(LARC) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.1.3 Bayer Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.2.3 Merck Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Teva Pharmaceutical
13.3.1 Teva Pharmaceutical Company Information
13.3.2 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceutical Main Business Overview
13.3.5 Teva Pharmaceutical Latest Developments
13.4 Allergan
13.4.1 Allergan Company Information
13.4.2 Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.4.3 Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Allergan Main Business Overview
13.4.5 Allergan Latest Developments
13.5 HRA Pharma
13.5.1 HRA Pharma Company Information
13.5.2 HRA Pharma Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.5.3 HRA Pharma Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 HRA Pharma Main Business Overview
13.5.5 HRA Pharma Latest Developments
13.6 Eurogine
13.6.1 Eurogine Company Information
13.6.2 Eurogine Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.6.3 Eurogine Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Eurogine Main Business Overview
13.6.5 Eurogine Latest Developments
13.7 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
13.7.1 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Company Information
13.7.2 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.7.3 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Main Business Overview
13.7.5 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Latest Developments
13.8 Wuxi Tianyi Medical Equipment Co., Ltd.
13.8.1 Wuxi Tianyi Medical Equipment Co., Ltd. Company Information
13.8.2 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.8.3 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Wuxi Tianyi Medical Equipment Co., Ltd. Main Business Overview
13.8.5 Wuxi Tianyi Medical Equipment Co., Ltd. Latest Developments
13.9 SMB Corporation
13.9.1 SMB Corporation Company Information
13.9.2 SMB Corporation Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.9.3 SMB Corporation Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 SMB Corporation Main Business Overview
13.9.5 SMB Corporation Latest Developments
13.10 Shenyang Liren
13.10.1 Shenyang Liren Company Information
13.10.2 Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.10.3 Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shenyang Liren Main Business Overview
13.10.5 Shenyang Liren Latest Developments
13.11 Tianjin Hejie Medical Equipment Co., Ltd.
13.11.1 Tianjin Hejie Medical Equipment Co., Ltd. Company Information
13.11.2 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.11.3 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tianjin Hejie Medical Equipment Co., Ltd. Main Business Overview
13.11.5 Tianjin Hejie Medical Equipment Co., Ltd. Latest Developments
13.12 Cooper Companies
13.12.1 Cooper Companies Company Information
13.12.2 Cooper Companies Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.12.3 Cooper Companies Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Cooper Companies Main Business Overview
13.12.5 Cooper Companies Latest Developments
13.13 AbbVie Allergan
13.13.1 AbbVie Allergan Company Information
13.13.2 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.13.3 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AbbVie Allergan Main Business Overview
13.13.5 AbbVie Allergan Latest Developments
13.14 Organon
13.14.1 Organon Company Information
13.14.2 Organon Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.14.3 Organon Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Organon Main Business Overview
13.14.5 Organon Latest Developments
13.15 Shanghai Dahua Pharmaceutical
13.15.1 Shanghai Dahua Pharmaceutical Company Information
13.15.2 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
13.15.3 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Shanghai Dahua Pharmaceutical Main Business Overview
13.15.5 Shanghai Dahua Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-Acting Reversible Contraception(LARC) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Long-Acting Reversible Contraception(LARC) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Intrauterine Devices (IUCs)
Table 4. Major Players of Subcutaneous Implant
Table 5. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2023) & (K Units)
Table 6. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
Table 7. Global Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2023)
Table 9. Global Long-Acting Reversible Contraception(LARC) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2023) & (K Units)
Table 11. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2023)
Table 12. Global Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2023)
Table 13. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2018-2023)
Table 14. Global Long-Acting Reversible Contraception(LARC) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Long-Acting Reversible Contraception(LARC) Sales by Company (2018-2023) & (K Units)
Table 16. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company (2018-2023)
Table 17. Global Long-Acting Reversible Contraception(LARC) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company (2018-2023)
Table 19. Global Long-Acting Reversible Contraception(LARC) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Long-Acting Reversible Contraception(LARC) Producing Area Distribution and Sales Area
Table 21. Players Long-Acting Reversible Contraception(LARC) Products Offered
Table 22. Long-Acting Reversible Contraception(LARC) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Long-Acting Reversible Contraception(LARC) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Long-Acting Reversible Contraception(LARC) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Long-Acting Reversible Contraception(LARC) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Long-Acting Reversible Contraception(LARC) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2018-2023)
Table 35. Americas Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2018-2023)
Table 37. Americas Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2018-2023)
Table 41. APAC Long-Acting Reversible Contraception(LARC) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2018-2023)
Table 43. APAC Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2018-2023)
Table 47. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2018-2023)
Table 49. Europe Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Long-Acting Reversible Contraception(LARC)
Table 58. Key Market Challenges & Risks of Long-Acting Reversible Contraception(LARC)
Table 59. Key Industry Trends of Long-Acting Reversible Contraception(LARC)
Table 60. Long-Acting Reversible Contraception(LARC) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Long-Acting Reversible Contraception(LARC) Distributors List
Table 63. Long-Acting Reversible Contraception(LARC) Customer List
Table 64. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Long-Acting Reversible Contraception(LARC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Long-Acting Reversible Contraception(LARC) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Long-Acting Reversible Contraception(LARC) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Long-Acting Reversible Contraception(LARC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bayer Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 79. Bayer Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 80. Bayer Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bayer Main Business
Table 82. Bayer Latest Developments
Table 83. Merck Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 85. Merck Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Teva Pharmaceutical Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 90. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Teva Pharmaceutical Main Business
Table 92. Teva Pharmaceutical Latest Developments
Table 93. Allergan Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 94. Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 95. Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Allergan Main Business
Table 97. Allergan Latest Developments
Table 98. HRA Pharma Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 99. HRA Pharma Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 100. HRA Pharma Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. HRA Pharma Main Business
Table 102. HRA Pharma Latest Developments
Table 103. Eurogine Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 104. Eurogine Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 105. Eurogine Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Eurogine Main Business
Table 107. Eurogine Latest Developments
Table 108. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 109. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 110. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Main Business
Table 112. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Latest Developments
Table 113. Wuxi Tianyi Medical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 114. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 115. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Wuxi Tianyi Medical Equipment Co., Ltd. Main Business
Table 117. Wuxi Tianyi Medical Equipment Co., Ltd. Latest Developments
Table 118. SMB Corporation Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 119. SMB Corporation Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 120. SMB Corporation Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. SMB Corporation Main Business
Table 122. SMB Corporation Latest Developments
Table 123. Shenyang Liren Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 124. Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 125. Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Shenyang Liren Main Business
Table 127. Shenyang Liren Latest Developments
Table 128. Tianjin Hejie Medical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 129. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 130. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Tianjin Hejie Medical Equipment Co., Ltd. Main Business
Table 132. Tianjin Hejie Medical Equipment Co., Ltd. Latest Developments
Table 133. Cooper Companies Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 134. Cooper Companies Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 135. Cooper Companies Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Cooper Companies Main Business
Table 137. Cooper Companies Latest Developments
Table 138. AbbVie Allergan Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 139. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 140. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. AbbVie Allergan Main Business
Table 142. AbbVie Allergan Latest Developments
Table 143. Organon Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 144. Organon Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 145. Organon Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Organon Main Business
Table 147. Organon Latest Developments
Table 148. Shanghai Dahua Pharmaceutical Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 149. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 150. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Shanghai Dahua Pharmaceutical Main Business
Table 152. Shanghai Dahua Pharmaceutical Latest Developments
Table 1. Long-Acting Reversible Contraception(LARC) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Long-Acting Reversible Contraception(LARC) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Intrauterine Devices (IUCs)
Table 4. Major Players of Subcutaneous Implant
Table 5. Global Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2023) & (K Units)
Table 6. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
Table 7. Global Long-Acting Reversible Contraception(LARC) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2023)
Table 9. Global Long-Acting Reversible Contraception(LARC) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2023) & (K Units)
Table 11. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2023)
Table 12. Global Long-Acting Reversible Contraception(LARC) Revenue by Application (2018-2023)
Table 13. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2018-2023)
Table 14. Global Long-Acting Reversible Contraception(LARC) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Long-Acting Reversible Contraception(LARC) Sales by Company (2018-2023) & (K Units)
Table 16. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company (2018-2023)
Table 17. Global Long-Acting Reversible Contraception(LARC) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company (2018-2023)
Table 19. Global Long-Acting Reversible Contraception(LARC) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Long-Acting Reversible Contraception(LARC) Producing Area Distribution and Sales Area
Table 21. Players Long-Acting Reversible Contraception(LARC) Products Offered
Table 22. Long-Acting Reversible Contraception(LARC) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Long-Acting Reversible Contraception(LARC) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Long-Acting Reversible Contraception(LARC) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Long-Acting Reversible Contraception(LARC) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Long-Acting Reversible Contraception(LARC) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2018-2023)
Table 35. Americas Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2018-2023)
Table 37. Americas Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Long-Acting Reversible Contraception(LARC) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2018-2023)
Table 41. APAC Long-Acting Reversible Contraception(LARC) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2018-2023)
Table 43. APAC Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2018-2023)
Table 47. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2018-2023)
Table 49. Europe Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Long-Acting Reversible Contraception(LARC)
Table 58. Key Market Challenges & Risks of Long-Acting Reversible Contraception(LARC)
Table 59. Key Industry Trends of Long-Acting Reversible Contraception(LARC)
Table 60. Long-Acting Reversible Contraception(LARC) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Long-Acting Reversible Contraception(LARC) Distributors List
Table 63. Long-Acting Reversible Contraception(LARC) Customer List
Table 64. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Long-Acting Reversible Contraception(LARC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Long-Acting Reversible Contraception(LARC) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Long-Acting Reversible Contraception(LARC) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Long-Acting Reversible Contraception(LARC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Long-Acting Reversible Contraception(LARC) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Long-Acting Reversible Contraception(LARC) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bayer Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 79. Bayer Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 80. Bayer Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bayer Main Business
Table 82. Bayer Latest Developments
Table 83. Merck Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 85. Merck Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Teva Pharmaceutical Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 90. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Teva Pharmaceutical Main Business
Table 92. Teva Pharmaceutical Latest Developments
Table 93. Allergan Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 94. Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 95. Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Allergan Main Business
Table 97. Allergan Latest Developments
Table 98. HRA Pharma Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 99. HRA Pharma Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 100. HRA Pharma Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. HRA Pharma Main Business
Table 102. HRA Pharma Latest Developments
Table 103. Eurogine Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 104. Eurogine Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 105. Eurogine Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Eurogine Main Business
Table 107. Eurogine Latest Developments
Table 108. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 109. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 110. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Main Business
Table 112. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Latest Developments
Table 113. Wuxi Tianyi Medical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 114. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 115. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Wuxi Tianyi Medical Equipment Co., Ltd. Main Business
Table 117. Wuxi Tianyi Medical Equipment Co., Ltd. Latest Developments
Table 118. SMB Corporation Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 119. SMB Corporation Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 120. SMB Corporation Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. SMB Corporation Main Business
Table 122. SMB Corporation Latest Developments
Table 123. Shenyang Liren Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 124. Shenyang Liren Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 125. Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Shenyang Liren Main Business
Table 127. Shenyang Liren Latest Developments
Table 128. Tianjin Hejie Medical Equipment Co., Ltd. Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 129. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 130. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Tianjin Hejie Medical Equipment Co., Ltd. Main Business
Table 132. Tianjin Hejie Medical Equipment Co., Ltd. Latest Developments
Table 133. Cooper Companies Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 134. Cooper Companies Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 135. Cooper Companies Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Cooper Companies Main Business
Table 137. Cooper Companies Latest Developments
Table 138. AbbVie Allergan Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 139. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 140. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. AbbVie Allergan Main Business
Table 142. AbbVie Allergan Latest Developments
Table 143. Organon Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 144. Organon Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 145. Organon Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Organon Main Business
Table 147. Organon Latest Developments
Table 148. Shanghai Dahua Pharmaceutical Basic Information, Long-Acting Reversible Contraception(LARC) Manufacturing Base, Sales Area and Its Competitors
Table 149. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product Portfolios and Specifications
Table 150. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Shanghai Dahua Pharmaceutical Main Business
Table 152. Shanghai Dahua Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-Acting Reversible Contraception(LARC)
Figure 2. Long-Acting Reversible Contraception(LARC) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-Acting Reversible Contraception(LARC) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Long-Acting Reversible Contraception(LARC) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Long-Acting Reversible Contraception(LARC) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Intrauterine Devices (IUCs)
Figure 10. Product Picture of Subcutaneous Implant
Figure 11. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type in 2022
Figure 12. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2023)
Figure 13. Long-Acting Reversible Contraception(LARC) Consumed in Age 20~24 Years Old
Figure 14. Global Long-Acting Reversible Contraception(LARC) Market: Age 20~24 Years Old (2018-2023) & (K Units)
Figure 15. Long-Acting Reversible Contraception(LARC) Consumed in Age 25-34 Years Old
Figure 16. Global Long-Acting Reversible Contraception(LARC) Market: Age 25-34 Years Old (2018-2023) & (K Units)
Figure 17. Long-Acting Reversible Contraception(LARC) Consumed in Age 35~44 Years Old
Figure 18. Global Long-Acting Reversible Contraception(LARC) Market: Age 35~44 Years Old (2018-2023) & (K Units)
Figure 19. Long-Acting Reversible Contraception(LARC) Consumed in Other
Figure 20. Global Long-Acting Reversible Contraception(LARC) Market: Other (2018-2023) & (K Units)
Figure 21. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2022)
Figure 22. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application in 2022
Figure 23. Long-Acting Reversible Contraception(LARC) Sales Market by Company in 2022 (K Units)
Figure 24. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company in 2022
Figure 25. Long-Acting Reversible Contraception(LARC) Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company in 2022
Figure 27. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Long-Acting Reversible Contraception(LARC) Sales 2018-2023 (K Units)
Figure 30. Americas Long-Acting Reversible Contraception(LARC) Revenue 2018-2023 ($ Millions)
Figure 31. APAC Long-Acting Reversible Contraception(LARC) Sales 2018-2023 (K Units)
Figure 32. APAC Long-Acting Reversible Contraception(LARC) Revenue 2018-2023 ($ Millions)
Figure 33. Europe Long-Acting Reversible Contraception(LARC) Sales 2018-2023 (K Units)
Figure 34. Europe Long-Acting Reversible Contraception(LARC) Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue 2018-2023 ($ Millions)
Figure 37. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Country in 2022
Figure 38. Americas Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country in 2022
Figure 39. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
Figure 40. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2023)
Figure 41. United States Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Region in 2022
Figure 46. APAC Long-Acting Reversible Contraception(LARC) Revenue Market Share by Regions in 2022
Figure 47. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
Figure 48. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2023)
Figure 49. China Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Country in 2022
Figure 57. Europe Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country in 2022
Figure 58. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
Figure 59. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2023)
Figure 60. Germany Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2023)
Figure 69. Egypt Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Long-Acting Reversible Contraception(LARC) in 2022
Figure 75. Manufacturing Process Analysis of Long-Acting Reversible Contraception(LARC)
Figure 76. Industry Chain Structure of Long-Acting Reversible Contraception(LARC)
Figure 77. Channels of Distribution
Figure 78. Global Long-Acting Reversible Contraception(LARC) Sales Market Forecast by Region (2024-2029)
Figure 79. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Long-Acting Reversible Contraception(LARC)
Figure 2. Long-Acting Reversible Contraception(LARC) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-Acting Reversible Contraception(LARC) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Long-Acting Reversible Contraception(LARC) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Long-Acting Reversible Contraception(LARC) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Intrauterine Devices (IUCs)
Figure 10. Product Picture of Subcutaneous Implant
Figure 11. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type in 2022
Figure 12. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2018-2023)
Figure 13. Long-Acting Reversible Contraception(LARC) Consumed in Age 20~24 Years Old
Figure 14. Global Long-Acting Reversible Contraception(LARC) Market: Age 20~24 Years Old (2018-2023) & (K Units)
Figure 15. Long-Acting Reversible Contraception(LARC) Consumed in Age 25-34 Years Old
Figure 16. Global Long-Acting Reversible Contraception(LARC) Market: Age 25-34 Years Old (2018-2023) & (K Units)
Figure 17. Long-Acting Reversible Contraception(LARC) Consumed in Age 35~44 Years Old
Figure 18. Global Long-Acting Reversible Contraception(LARC) Market: Age 35~44 Years Old (2018-2023) & (K Units)
Figure 19. Long-Acting Reversible Contraception(LARC) Consumed in Other
Figure 20. Global Long-Acting Reversible Contraception(LARC) Market: Other (2018-2023) & (K Units)
Figure 21. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2022)
Figure 22. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application in 2022
Figure 23. Long-Acting Reversible Contraception(LARC) Sales Market by Company in 2022 (K Units)
Figure 24. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Company in 2022
Figure 25. Long-Acting Reversible Contraception(LARC) Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Company in 2022
Figure 27. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Long-Acting Reversible Contraception(LARC) Sales 2018-2023 (K Units)
Figure 30. Americas Long-Acting Reversible Contraception(LARC) Revenue 2018-2023 ($ Millions)
Figure 31. APAC Long-Acting Reversible Contraception(LARC) Sales 2018-2023 (K Units)
Figure 32. APAC Long-Acting Reversible Contraception(LARC) Revenue 2018-2023 ($ Millions)
Figure 33. Europe Long-Acting Reversible Contraception(LARC) Sales 2018-2023 (K Units)
Figure 34. Europe Long-Acting Reversible Contraception(LARC) Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue 2018-2023 ($ Millions)
Figure 37. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Country in 2022
Figure 38. Americas Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country in 2022
Figure 39. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
Figure 40. Americas Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2023)
Figure 41. United States Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Region in 2022
Figure 46. APAC Long-Acting Reversible Contraception(LARC) Revenue Market Share by Regions in 2022
Figure 47. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
Figure 48. APAC Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2023)
Figure 49. China Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Country in 2022
Figure 57. Europe Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country in 2022
Figure 58. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
Figure 59. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2023)
Figure 60. Germany Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2018-2023)
Figure 69. Egypt Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Long-Acting Reversible Contraception(LARC) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Long-Acting Reversible Contraception(LARC) in 2022
Figure 75. Manufacturing Process Analysis of Long-Acting Reversible Contraception(LARC)
Figure 76. Industry Chain Structure of Long-Acting Reversible Contraception(LARC)
Figure 77. Channels of Distribution
Figure 78. Global Long-Acting Reversible Contraception(LARC) Sales Market Forecast by Region (2024-2029)
Figure 79. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Long-Acting Reversible Contraception(LARC) Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share Forecast by Application (2024-2029)
